Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids (original) (raw)
Design synthesis and evaluation of anticancer activity of heterocyclic compounds
ojaswi ghadge
Shodhganga, 2019
View PDFchevron_right
Synthesis and in vitro anticancer evaluation of 8b-hydroxy-1-(6-substitutedbenzo[d]thiazol-2-yl)-3-(3-substitutedphenyl)-1,8b-dihydroindeno[1,2-c]pyrazol-4(3aH)-ones
Satbir Mor
Journal of Molecular Structure, 2022
View PDFchevron_right
New triarylpyrazoles as broad-spectrum anticancer agents: Design, synthesis, and biological evaluation
Dae Yoon Chi
European Journal of Medicinal Chemistry, 2013
View PDFchevron_right
Design Synthesis and Evaluation of Novel Anticancer Agents
Mahaveer Singh
2017
View PDFchevron_right
Novel Anticancer Strategies
Hassan Bousbaa
Pharmaceutics, 2021
View PDFchevron_right
Synthesis of New 4-Thiazolidinone-, Pyrazoline-, and Isatin-Based Conjugates with Promising Antitumor Activity
Roman Lesyk
Journal of Medicinal Chemistry, 2012
View PDFchevron_right
Pteridine–sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activity
M. Amélia Santos
Bioorganic & Medicinal Chemistry, 2010
View PDFchevron_right
Anti-Cancer Agents in Medicinal Chemistry
Chinweike Eze
Bentham sciences, 2022
View PDFchevron_right
Novel Anticancer Strategies II
Hassan Bousbaa
Pharmaceutics
View PDFchevron_right
An Insight into Cancer and Anticancer Drugs
Raichel Nivetha
Acta Scientific Medical Sciences
View PDFchevron_right
Carbonic anhydrase inhibitors: Synthesis and inhibition studies against mammalian isoforms I–XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides
Franciszek Sączewski
Bioorganic & Medicinal Chemistry, 2008
View PDFchevron_right
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole
Giampietro Viola
Scientific reports, 2016
View PDFchevron_right
Synthesis and in vitro anticancer activity of novel thiazacridine derivatives
Júlia Campos
Medicinal Chemistry Research, 2012
View PDFchevron_right
Design and Synthesis of DNA-Interactive β-Carboline-Oxindole Hybrids as Cytotoxic and Apoptosis-Inducing Agents
Nagula Shankaraiah
ChemMedChem, 2018
View PDFchevron_right
Design, Synthesis, Anticancer Evaluation, Enzymatic Assays, and a Molecular Modeling Study of Novel Pyrazole–Indole Hybrids
Gaber Osman
ACS omega, 2021
View PDFchevron_right
Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX
Kamal Ahmad
European journal of medicinal chemistry, 2017
View PDFchevron_right
molecules Synthesis and in Vitro Screening of Phenylbipyridinylpyrazole Derivatives as Potential Antiproliferative Agents
Soo Ha, Ahmed Elkamhawy
View PDFchevron_right
Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents
Iqbal Azad
Journal of Molecular Graphics & Modelling, 2018
View PDFchevron_right
Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer
Ahmed Reda
Bioorganic chemistry, 2018
View PDFchevron_right
The Anticancer Activity for the Bumetanide-Based Analogs via Targeting the Tumor-Associated Membrane-Bound Human Carbonic Anhydrase-IX Enzyme
AHDAB KHAYYAT
Pharmaceuticals
View PDFchevron_right
Synthesis, in silico and in vitro evaluation of new 3,5-disubstituted-1,2,4-oxadiazole derivatives as carbonic anhydrase inhibitors and cytotoxic agents
Dilek Bul
Journal of Molecular Structure, 2023
View PDFchevron_right
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds
Alessandro Cecchi
Bioorganic & Medicinal Chemistry Letters, 2005
View PDFchevron_right
New Anticancer Agents: Recent Developments in Tumor Therapy
Ghazi Damanhouri
Anticancer Research, 2012
View PDFchevron_right
DESIGN, SYNTHESIS AND IN VITRO ANTI-CANCER ACTIVITY OF NOVEL 1,2,4-TRIAZOLE DERIVATIVES Original Article
Madhusudan Purohit
View PDFchevron_right
Synthesis and in-vitro anticancer activity of 3-cyano-6,9-dimethyl-4-imino 2-methylthio 4H-pyrimido [2,1- b ] [1,3] benzothiazole and its 2-substituted derivatives
Gangadhar Waghmare
Journal of Pharmacy Research, 2013
View PDFchevron_right
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide
Alessandro Cecchi
Bioorganic & Medicinal Chemistry Letters, 2004
View PDFchevron_right
DESIGN, SYNTHESIS AND IN VITRO ANTI-CANCER ACTIVITY OF NOVEL 1,2,4-TRIAZOLE DERIVATIVES
International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS), ESHWAR M. S.
International journal of Pharmacy and Pharmaceutical Sciences, 2014
View PDFchevron_right
Synthetic and Naturally Occurring Heterocyclic Anticancer Compounds with Multiple Biological Targets
RICHARD KWAMLA AMEWU
Molecules, 2021
View PDFchevron_right
Design, synthesis, in silico and biological evaluation of biotin-pyrazole derivatives as anti-cancer activity
Vishwanath Zunjar
Organic communications, 2022
View PDFchevron_right
New selective carbonic anhydrase IX inhibitors: Synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides
Laurence Goossens
Bioorganic & Medicinal Chemistry, 2013
View PDFchevron_right
Synthesis and anticancer activity of new 1-[(5 or 6-substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives
Young Lee
2010
View PDFchevron_right
Discovery of a New Potent Oxindole Multi-kinase Inhibitor Among a Series of Designed 3-Alkenyl-oxindoles with ancillary Carbonic Anhydrase Inhibitory activity as antiproliferative agents
Hanan Georgey
View PDFchevron_right
New Sulfamethoxazole Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors: Design, Synthesis, Cytotoxic Activity and Molecular Modeling
Hamud Altaleb
Pharmaceuticals
View PDFchevron_right